A Breakthrough in Health: How GLP-1s Are Redefining Pharma with David Ricks and Fatima Cody Stanford

David Ricks and Dr. Fatima Cody Stanford talk through the groundbreaking role of GLP-1 medications in transforming the treatment of obesity, and how they might reshape the future of health care, in this interview with Andrew Ross Sorkin at the 2024 New York Times DealBook Summit.

Interviewer: Andrew Ross Sorkin, the founder and editor at large of DealBook

Guests: David Ricks, the chair and C.E.O. of Eli Lilly and Company, and Fatima Cody Stanford, M.D., M.P.H., M.P.A., M.B.A. an obesity medicine physician at Massachusetts General Hospital/Harvard Medical School

Скачать видео